Researchers at IISER Bhopal have found that depleting the production of a specific protein kinase (PAK2) has a cascading effect in head and neck cancer. The expression of both cancer gene (c-Myc) and cancer-specific metabolic enzyme (PKM2) gets compromised when PAK2 protein is depleted. Inhibitors developed to target the PAK2 protein are more likely to be successful in treating head and neck cancer and reducing resistance to cancer drugs.
Like this:
Like Loading...
Related
Published by Prasad Ravindranath
Science Editor with @The_Hindu, Chennai, India.
DO GET IN TOUCH WITH ME AT prasad.thehindu@gmail.com IF YOU HAVE SOME INTERESTING RESULTS THAT CAN BE PUBLISHED IN THE HINDU NEWSPAPER AND ALSO IN MY BLOG. You can also reach me on twitter @RPrasad12 and Facebook /prasad.ravindranath.
I write on health, medicine, environment, and technology.
View all posts by Prasad Ravindranath
